Evaluation of Solid Ultrasound Breast Nodules

Rodrigo Arrangoiz MS, MD, FACS, FSSO

👉 The American College of Radiology BI-RADS classification subdivides:

– BI-RADS 0 incomplete evaluation, requieres additional imaging evaluation

– BI-RADS 1 normal, which has a 0% risk of malignancy

– BI-RADS 2 benign finding, which has a 0% risk of malignancy

– BI-RADS 3 probably benign, with a ≤2 risk of malignancy

– BI-RADS 4a mildly suspicious, which has a 2% to 10 % risk of malignancy,

– BI-RADS 4b moderately suspicious, which has 10% to 50 % risk of malignancy

– BI-RADS 4c highly suspicious, which has a 50% to 95% risk of malignancy

– BI-RADS 5 malignant, has 95% or greater chance of malignancy

👉 In evaluating a solid sonographic nodule:

– One should first look for any of the 10 signs of malignancy, and if even one of them is present, the lesion cannot be considered BI-RADS 3.

👉 The 10 signs of malignancy are:

– Shadowing

– Hypoechoic echotexture

– Spiculation

– Angular margins

– Thick echogenic halo

– Microlobulation

– Taller than wide

– Duct extension

– Branching pattern

– Calcifications

👉 It should be noted that Stavros compares the echogenicity of lesions to that of breast fat, not breast parenchyma:

– Therefore, a lesion with hypoechoic echotexture would be very hypoechoic if breast parenchyma is used as the reference

👉👉 Rodrigo Arrangoiz MS, MD, FACS cirujano oncology y cirujano de mamá de Sociedad Quirúrgica S.C en el America British Cowdray Medical Center en la ciudad de Mexico:

  • Es experto en el manejo del cáncer de mama.

👉 Es miembro de la American Society of Breast Surgeons:

Training:

• General surgery:

• Michigan State University:

• 2004 al 2010

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Masters in Science (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016

#Arrangoiz

#Surgeon

#Cirujano

#SurgicalOncologist

#CirujanoOncologo

#BreastSurgeon

#CirujanodeMama

#CancerSurgeon

#CirujanodeCancer

Unknown's avatar

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

Leave a comment